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Abstract—Large-scale population-based studies in medicine
are a key resource towards better diagnosis, monitoring, and
treatment of diseases. They also serve as enablers of clinical
decision support systems, in particular Computer Aided Di-
agnosis (CADx) using machine learning (ML). Numerous ML
approaches for CADx have been proposed in literature. However,
these approaches assume full data availability, which is not always
feasible in clinical data. To account for missing data, incomplete
data samples are either removed or imputed, which could lead to
data bias and may negatively affect classification performance.
As a solution, we propose an end-to-end learning of imputation
and disease prediction of incomplete medical datasets via Multi-
graph Geometric Matrix Completion (MGMC). MGMC uses
multiple recurrent graph convolutional networks, where each
graph represents an independent population model based on
a key clinical meta-feature like age, sex, or cognitive function.
Graph signal aggregation from local patient neighborhoods,
combined with multi-graph signal fusion via self-attention, has
a regularizing effect on both matrix reconstruction and classifi-
cation performance. Our proposed approach is able to impute
class relevant features as well as perform accurate classification
on two publicly available medical datasets. We empirically show
the superiority of our proposed approach in terms of classification
and imputation performance when compared with state-of-the-
art approaches. MGMC enables disease prediction in multi-
modal and incomplete medical datasets. These findings could
serve as baseline for future CADx approaches which utilize
incomplete datasets.
Index Terms—Computer-aided diagnosis, CADx, Deep Learn-
ing, Multimodal medical data, Population-based studies
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LARGE population-based studies in medicine, acquiredat multiple institutions, are instrumental resources for
a better clinical understanding of the diagnosis, progression
and treatment of diseases. In medical health informatics, they
serve as fundamental enablers for the design and analysis of
novel clinical decision support systems (CDSS) and Computer
Aided Diagnosis (CADx) [1], [2], [3]. Often, such datasets
incorporate multimodal data (imaging and non-imaging), in
order to capture as many aspects of the disease as possible.
Another characteristic is the occurrence of missing data, which
is difficult to prevent [4]. Missingness occurs both on a
feature-level, e.g. after outlier removal due to low-quality
data acquisition, as well as on a modality-level, e.g. when
an examination was too costly or not sufficiently indicated.
Two prominent examples for such datasets in neurology
and neuroscience were published by the Alzheimer’s Disease
(AD) Neuroimaging Initiative (ADNI) [5] and the Parkinson’s
disease (PD) Progressive Marker Initiative (PPMI) [6]. To-
gether, AD and PD are the most common neurodegenerative
diseases, with AD accounting for 60-80% of dementia cases,
and PD affecting 12% of the global population over the age of
65. Neurodegenerative diseases result in a progressive decay
and death of nerve cells [7]. Increasing rates of up to a
million new AD cases per year [8], and the prospect of novel
neuroprotective and disease-modifying therapeutics, in both
AD [9] and PD [10], motivate an early diagnosis of these
diseases, ideally already at a pre-symptomatic stage.
Related works: Among ML-based CADx approaches,
Thung et al. [11], [12] use Low-Rank Matrix Completion
(LRMC) to predict conversion of the disease in patients with
Mild Cognitive Impairment (MCI) to Alzheimers Disease
(AD). Zhou et al. [13] proposed to solve AD diagnosis using
latent representation learning, by projecting both complete
and incomplete modalities onto a common subspace. Both
approaches by [12] and [13] assume a linear relationship
between the input features and the target variable, and latent
embeddings and linear classification are trained in two separate
steps [13], which does not take advantage of end-to-end
learning.
A recent development in non-linear signal processing on
unstructured domains is geometric deep learning [14]. A
breakthrough paper in this domain was the first demonstration
of semi-supervised classification using graph convolutional
neural networks (GCN) [15]. GCNs solve classification by
learning optimal filters in the graph spectral domain. These
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filters perform non-linear message passing between vertices, in
order to map high-dimensional signals to labels for all vertices
in the graph. Parisot et al. [16] transferred this approach
to CADx in medicine, by introducing a novel concept for
modeling patient populations as a graph: patient meta-data
like demographics (e.g. sex, age, etc.) are used to compute
similarities between patients, leading to an adjacency matrix
with an associated graph Laplacian. Intuitively, the graph then
represents the ”social network” of patients in the cohort. As
has been shown in several works, [17], [16], [18], [19], [20],
[21], GCNs can significantly improve the accuracy of CADx in
medicine. Importantly, the CADx accuracy crucially depends
on a meaningful graph representation of the cohort. To make
GCNs more robust towards the patient similarity measures
and graph construction, we have shown previously that it is
beneficial to construct multiple graphs, one for each meta-
feature, and fuse their processed features towards the decision
layer, e.g. through attention mechanisms [18], [19].
Regarding incomplete datasets, Monti et al. [22] showed that
geometric deep learning provides a principled framework for
non-linear imputation, through geometric matrix completion
(GMC) using GCNs and LSTMs. The target application were
recommender systems, where a signal matrix denotes how
users (rows) rank different items (columns). Naturally, user
ratings are highly incomplete, and as such the signal matrix
is sparsely populated. Through meta-data, two graphs can
be constructed which represent the social network between
users (row graph) and the semantic similarities between items
(column graph). In GMC, the incomplete matrix and the two
graphs serve as input to a GCN, which learns appropriate
filters for non-linear signal diffusion on the graph domains,
such that the entire completed matrix is reconstructed at the
output. Essentially, the method learns to reconstruct the known
entries in the sparse feature matrix, and fills missing entries as
a side effect, purely through non-linear global signal diffusion.
In our own previous work [23], we utilized multi-target
training to combine GMC with supervised classification into
a Recurrent Graph Convolutional Network (RGCN). Similar
to Parisot et al. [16], we constructed a patient graph from
clinically relevant meta-data (e.g. age and sex of patients).
We concatenated the incomplete feature matrix and incomplete
labels, and trained a GCN for signal diffusion, along with
a Long-Short Term Memory (LSTM) network for iterative
matrix reconstruction. Both GCN and LSTM were trained end-
to-end towards MCI to AD conversion prediction, with two
weighted losses for simultaneous classification and imputation.
Proposed approach: Building up on our previous works
in [23], [19], we propose to solve disease classification in
multimodal and incomplete datasets using Multi-graph Ge-
ometric Matrix Completion (MGMC). The contributions of
this work are threefold: 1) we formulate the disease classifi-
cation problem in multimodal and incomplete datasets using
MGMC; 2), we propose a novel method which uses multiple
non-autoregressive Recurrent Graph Convolutional Networks
(RGCN); 3) we validate the superiority of the proposed
approach on publicly available medical dataset and evaluate
the effect of autoregressive LSTMs on MGMC architectures.
II. MATERIALS AND PREPROCESSING
A. Dataset and Preprocessing
We used two publicly available datasets in this work: The
Alzheimer’s Disease Prediction Of Longitudinal Evolution
(TADPOLE) [5] obtained from the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI) database (adni.loni.usc.edu) and
the Parkinson’s Progressive Marker Initiative (PPMI) dataset
[6]. TADPOLE requires classification of subjects into three
categories, normal control (NC), mild cognitive impairement
(MCI), and Alzheimer’s disease (AD). PPMI requires detec-
tion of Parkinson’s disease (PD) vs. normal controls (NC).
In TADPOLE, we used 813 subjects coming from the ADNI
protocol with 229 NC, 396 MCI and 188 AD diagnosed
at baseline. This dataset contains pre-processed features [5]
from cerebro-spinal fluid (CSF) markers, magnetic resonance
imaging (MRI), positron emission tomography FDG (PET),
diffusion tensor imaging (DTI), cognitive assessment scores,
genetic information such as alipoprotein E4 (APOE4), and
demographic information. Further pre-processing entailed a
normalization of real-valued TADPOLE features to zero-mean
and unit-variance. To match the classification task, we selected
only features at baseline, and excluded features containing
longitudinal information. We further removed features that
were available for less than 10% of the available entries. In
the end, the feature matrix had a dimensionality of 813 × 435,
excluding label information.
In the PPMI dataset, we used all 75 healthy controls (HC)
and 249 subjects with PD. PPMI data consists of brain MRI as
well as non-imaging information such as Unified Parkinson’s
Disease Rating Scale (UPDRS), Montreal Cognitive Assess-
ment (MoCA) scores, and demographic information (age and
gender). The MRI information is used as input to the network
while non-imaging information is used for the graph construc-
tion. As described in our previous GCN CADx approach [19],
we pre-processed MRI volumes by co-registering each images
to a normative space (SRI24 atlas [24]) to reduce variability
in appearance , and further performed skull stripping using
ROBEX [25]. Then we scaled each volume to an intensity
range of [0,1]. Finally, to obtain a lower dimensional rep-
resentation as input to the graph network, we used encoded
raw image intensities coming from a 3D-autoencoder, which
was pretrained for towards anomaly detection. We refer the
reader to [26] for a detailed discussion on the implementation
of the pre-processing and 3D-autoencoder. The output at the
bottleneck layer of the 3D-autoecoder was then used as the
feature representation of the brain MRI volume.
Notably, our pre-processed PPMI dataset was 100% feature
complete. In contrast, the TADPOLE dataset is inherently
incomplete in native form, and was 83% feature-complete
after our pre-processing pipeline. In the experimental sec-
tion, we further removed known features artificially, to test
classification and imputation robustness at various levels of
data missingness. For better clarity throughout the rest of the
paper, when denoting e.g. 50% data availability, we refer to
the amount of data available at baseline (e.g. 50% for PPMI,
and 41.5% for TADPOLE).
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TABLE I: Description of Notations
Notation Dimension Description
X n×m Observed feature matrix with n samples and
m features
Y n× c Class label matrix with n samples and c num-
ber of class
Z n×(m+c) Concatenated X and Y matrices
Xˆ n×m Predicted feature matrix X
Zˆ n×(m+c) Predicted matrix Z
Z¯ n×(m+c) Predicted matrix Z from a single RGCN
||.||2F – Frobenius norm||.||2D,r – Dirichlet norm on the row graph
Lce(.) – Cross-entropy loss
LR(.) – Reconstruction loss from GMC
M(i) – The i-th meta-information
M – Set containing {M(1), ...,M(I)}
Gi – The i-th graph constructed using meta-
information M(i)
Ωx, Ωy – Denote whether input features and class lables,
respectively, are known (1) or missing (0)
Θ, δ – Parameters from GCN and LSTM, respectively
γ{a,b,c} – Hyper-parameters weighting loss terms
III. METHODS
We first introduce the notation used throughout the rest
of the paper in Table I then elaborate on key background
information in order to provide more context on our proposed
approach.
A. Graph Construction
We use meta-information to construct separate graphs
for each dataset. In the TADPOLE dataset, we use meta-
information such as age, gender, and genetic risk factor
(APOE4), all of which are known risk factors related to AD.
For every given meta-information we calculate a separate
graph using a pairwise similarity function. An edge between
nodes i and j is defined using W (i, j) = f(M(i),M(j))
where
f(M(i),M(j)) =
{
1 if |(M(i)−M(j)| ≤ θ
0 otherwise
(1)
M(i) and M(j) denote meta information of node i and j,
and θ denotes a threshold value which is chosen empirically.
To construct the graphs for the PPMI dataset, we use
the same formulation in equation (1) and build graphs for
every meta-information. Here we again use age and gender,
along with two PD-related clinical scores of motor function
(UPDRS) and of cognitive function (MoCA) to build the
graph, following [19].
B. Geometric Matrix Completion
Consider an incomplete feature matrix X ∈ Rn×m where
a certain proportion of values is missing at random. The goal
is to recover the missing values in this matrix. One solution
to this problem is by using rank minimization. However, as
this is known to be computationally intractable, an alternative
approximation is to constrain the predicted values to be smooth
with respect to some geometric structure [27], [28], [22]. Here
a graph structure is built based on the rows or columns of
the matrix. Monti et al. [22] proposed to solve this using
geometric deep learning on graphs, through a combination of
GCN and LSTM networks. Compared to GMC recommender
systems in [22], our CADx problem does not allow us to build
a semantically meaningful column graph, especially since
features stem from different modalities. Therefore, we modify
the GMC approach to consider only a row graph derived from
from patient similarities to model the population. Similarities
are computed from meta-features using the metric in equation
1. Pair-wise similarities between nodes in the population graph
connect patients that share the same risk-factor characteristics.
The row graph is then represented as G = (V,E,W), with
vertices V = {1, 2, ..., n}, and edges E ⊆ V × V , which
are weighted with non-negative weights. We represent the
graph with a symmetric adjacency matrix W ∈ Rn×n. The
geometric matrix completion problem when considering only
the row graph reduces to solving:
`(Θ, δ) = ||XˆΘ,δ||2D +
γ
2
||Ωx ◦ (XˆΘ,δ −X)||2F (2)
where XˆΘ,δ is the predicted matrix conditioned on the
parameters of the GCN and LSTM. In equation (2), the first
term on the right is equal to tr(XˆTLXˆ) which contains a
rescaled graph Laplacian (L ∈ Rn×n) term such that its
eigenvalues are in the interval [−1, 1]. This term keeps the
prediction smooth with respect to the row graph structure.
GMC can also be extended to multi-target training on het-
erogeneous matrix entries. Consider a matrix Z ∈ Rn×(m+c),
which contains a mixture of feature and label information,
which is implemented by concatenation of the feature matrix
X ∈ Rn×m and class label matrix Y ∈ Rn×c, similarly to
Goldberg et al. [29]. Following equation (2), we can add a
classification loss term on the imputed class label matrix [23].
The combined loss for completion of matrix Z is then:
`(Θ, δ) =
γa
2
||ZˆΘ,δ||2D +
γb
2
||Ωx ◦ (ZˆΘ,δ − Z)||2F
+ γc(Lce(ZˆΘ,δ ◦Ωy,Z ◦Ωy)) (3)
where ZˆΘ,δ is the predicted matrix containing predictions
for both Xˆ and Yˆ.
C. Multigraph Geometric Matrix Completion
MGMC1 consists of multiple non-autoregressive RGCNs
and Transformer-like self-attention. We first describe the
motivation why we use multiple RGCNs then elaborate on
the self-attention inspired aggregation scheme including the
use of non-autoregressive RGCNs. First, as we described
in our previous works [18], [19], the rules for constructing
a population graph from a medical dataset are crucial to
the accuracy of a GCN’s downstream task, e.g. diagnostic
classification accuracy. Instead of collapsing all meta-features
into a single patient similarity measure, we therefore construct
multiple graphs, one for each meta-feature. We then propose
to integrate multi-graph GCNs into matrix completion by
training a dedicated GCN and LSTM for each graph in an
end-to-end manner. We do this to learn better imputed feature
1Code: https://github.com/pydsgz/MGMC
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representations for each graph which could be useful in the
downstream classification task.
To aggregate separate signals from parallel RGCNs, we
use a self-attention aggregation mechanism inspired by Trans-
former networks [30]. We do this by training separate RGCNs
(which consists of GCN and LSTM) in an end-to-end manner
as shown in figure 1, then aggregate graph outputs using the
weights learned from the self-attention layer. Furthermore, we
use muliple RGCNs, wherein each (unrolled) RGCN consists
of a GCN and a non-autoregressive LSTM. Although the use
of multiple graphs and LSTMs have been used in previous
methods ([22], [21], one important difference of our proposed
approach is the use of non-autoregressive LSTMs. As shown
in figure 1, we only use the original input feature as input to
the next timestep including the learned parameters from the
previous LSTM cell-block. Such a non-autoregressive strategy
is motivated in several ways. First, it limits the number of
neighborhood hops and graph signal diffusion steps, as the
input feature matrix to the GCN layer is the same at every
time-step in the RGCN. Second, it allows the model to have
better control on which graph-relevant information is useful for
the imputation and downstream classification task. Third, by
using the original input features as prior information at every
optimization step, we reinforce the reconstruction of the input
data, and prevent the model from diverging from the input data.
As a result, this strategy prevents the model from suggesting
non-realistic features as outputs. For the GCN layers, we use
a Cheb-Net implementation [31], [22]. This uses a Chebyshev
polynomial basis (
∑K
k=0 Tk(L˜)XΘk) to represent the spectral
filters. For a more in-depth discussion regarding deep learning
on graphs we refer the reader to [14]. The optimization loss
for multi-graph GMC then boils down to solving:
`(Θ, δ) =
M∑
i
(
γa
2
||Z¯(i)Θ,δ||2D,r +
γb
2
||Ωx ◦ (Z¯(i)Θ,δ − Z)||2F)
+ γc(Lce(ZˆΘ,δ ◦Ωy,Z ◦Ωy)) (4)
where Z¯(i)Θ,δ is the i-th predicted matrix based from the i-th
graph (noting that this is conditioned on the parameters of the
i-th GCN and LSTM) and Zˆ(i)Θ,δ is the aggregated predicted
matrix coming from all GCNs and LSTMs.
IV. RESULTS
A. Implementation Details.
We split the dataset into 10% test and 90% train (of which
10% as validation set) on all methods. For all deep learning
based methods we use Adam optimization [32], with imple-
mentations in PyTorch [33], on a workstation with single-GPU
(Nvidia GTX 1080 Ti). We automatically determine hyperpa-
rameters in equation (4) using hyperparameter optimization
on the validation set with 120 iterations [34], with the follow-
ing search spaces for the Chebyshev Polynomial parameters
(K ∈ range(1, 20)), learning rate = uniform([0.00001, 0.1]),
intermediate layer hidden units ∈ range(8, 512), and γ(a,b,c)
= uniform([0.001, 1000])).
We compared the proposed method with shallow learning
methods in machine learning and state-of-the-art graph-based
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Fig. 1: Network architecture of MGMC which uses multiple
Recurrent Graph Convolutional Network (RGCN) (top) includ-
ing non-autoregressive RGCN layer (bottom).
methods which have shown to be highly effective for disease
prediction. For shallow learning, we used Logistic Regression
(LR) as the linear baseline, and Random Forest (RF) [35]
as a competitive non-linear baseline. Previous graph-based
methods included GCNs and GMC. As several algorithms
(LR, RF and GCN) assume feature-completeness, we first
need to impute the missing values in the feature matrix.
We used three approaches to accomplish this: the commonly
used mean imputation method, kNN imputation [36], and
the state-of-the-art MICE algorithm, the latter with random
regression forests for estimation [37]. To test imputation
performance, we artificially reduce the percentage of known
data in the ADNI/PPMI feature matrices and perform impu-
tation/classification at {100,75,50,25}% data availability. We
use Scikit-learn [38] implementations for cross-validation, pre-
processing, imputation and shallow classifier models (LR and
RF).
To make baseline algorithms as competitive as possible,
we also perform hyperparameter optimization (also 120 max.
iterations) for the standard machine learning models (i.e. LR
and RF) [39]. We concatenate the meta-features (e.g. demo-
graphics) with the feature vectors for all baseline methods, to
further ensure fairness, as our proposed graph-based method
utilizes this information as well (for graph construction).
B. PPMI and TADPOLE Dataset Results.
In Fig. 2 (left panel), we plot classification and imputation
results on the PPMI dataset. It is clearly visible that the
classification accuracy and AUC of LR and RF models are
consistently lower than our proposed approach. Since both
models require feature completeness, they operate on imputed
features. In the same AUC boxplots, we observe that the
proposed approach has significantly higher AUC than standard
machine learning models and previous graph-based methods
(GCN and GMC). We can also observe that the imputed
values of the proposed approach have a much lower absolute
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deviation (RMSE) from the real values than mean, MICE,
kNN, and GMC imputation.
Further, in Fig. 2 (right panel), compared to PPMI, the
classification accuracy does not benefit as clearly from the
population graph or imputation in our method. MultiGMC
still classifies better than linear methods, with a significant
advantage at lower percentage of data availability (25%). As
in PPMI, however, the imputation results in terms of RMSE
are significantly and consistently better than the baseline
imputation methods (mean, MICE, kNN). Similar to PPMI,
the trend is visible that baseline imputation methods impute
with higher RMSE errors as fewer data is available in the
feature matrix, whereas the MultiGMC provides fairly robust
imputation results.
We performed ablative experiments to see how non-
autoregressive LSTMs affect the imputation and classification
performance. In Fig. 3 left, we observe that for the PPMI
dataset, the non-autoregressive model yields significantly bet-
ter results in terms of AUC and Accuracy at all levels of
data missingness. For the TADPOLE dataset (Fig. 3 right), the
proposed method classifies comparably well at 50%, 75% and
100% data availability, but significantly outperforms the auto-
regressive model at 25% data availability, demonstrating better
classification robustness at lower levels of data availability.
V. DISCUSSION
A. Classification performance when using all available data
In PPMI, we observe that our proposed approach achieves
significantly better classification in terms of AUC and Ac-
curacy for PD prediction when compared with standard ML
models (LR and RF), as shown in Fig. 2 left. In TADPOLE, we
observe that our approach is mostly on a par with baseline ML
methods and SOTA approaches from literature. As mentioned
in the dataset descriptions, PPMI is 100% feature-complete
at baseline, whereas TADPOLE is only 83% complete at
baseline. It is noteworthy that at 100% data availability,
MGMC already performs imputation in TADPOLE, but we
cannot validate the imputed values due to a lack of groundtruth
data for those missing features. Compared to previous studies,
Zhou et al. [13] reported ∼60% classification accuracy and
∼0.6 AUC for the same AD classification problem posed in
this paper for the TADPOLE dataset. Gray et al. [40] reported
∼60% classification accuracy and ∼0.7 AUC. In our study,
we also achieve a classification accuracy on the order of
∼60%, however with higher AUC values on the order of ∼0.8.
To interpret these results, we recall that the accuracy metric
represents the number of true positive and true negative cases
among the total population, at a fixed threshold of the model’s
posterior. In comparison, the ROC-AUC gives an estimate of
the likelihood that a classifier simultaneously achieves a high
true positive rate and low false positive rate. This indicates
that MGMC, compared to related works, and compared to
baseline models at 25% data availability, achieves a more
robust classification outcome, not only in terms of sensitivity,
but also in form of a lower likelihood for type I errors. A
likely reason for the AUC difference of ∼0.1 compared to
[40] is that earlier (2013) versions of the ADNI dataset had
a smaller sample size, which also makes comparisons to our
work somewhat unfair. Compared to [13], the AUC difference
of ∼0.2 can be likely attributed to the use of multi-graph
convolutions in our work, which are trained end-to-end in a
semi-supervised manner.
B. Classification performance with artificially removed data
To investigate the robustness of MGMC and baseline meth-
ods with respect to missing data, we randomly reduce the
amount of available data in the feature matrix relative to the
number of observed entries at baseline, as shown in Fig. 2. We
observe that the proposed approach has better and more stable
classification and imputation results for PD prediction in PPMI
when more information is missing. This effect is particularly
visible in the AUC values, which may increase in standard
deviation over the ten cross validation folds, but stay relatively
stable in terms of median values above 0.9, even at low level
of data availability around 25%. In comparison, LR, RF and
GCN suffer from a noticeable drop in classification robustness.
Interestingly, the single-graph GMC also yields relatively
constant AUC values, but at a significantly lower level than
MGMC. This has two important implications. First, end-to-
end learning of simultaneous imputation and classification,
e.g. via geometric matrix completion, noticeably improves
the robustness of the CADx model towards the level of
incompleteness in datasets. Second, multiple graphs in parallel,
e.g. fused by self-attention, improve both downstream tasks
significantly, compared to using a single-graph. It is important
to note, however, that the two downstream tasks do not always
benefit equally. In TADPOLE, for example, we observe a
comparably stable classification performance at 75%, 50%
and 25% data availability. However, a similar behaviour is
observed for all other classifiers, and all classifiers in general
classify similarly well. Only at 25% data availability, MGMC
significantly outperforms GCN and LR (the latter two with
MICE imputation), but we consider this a negligible advan-
tage. Clearly, the main benefit of the proposed method on
TADPOLE data lies not in an improved classification, but in
a significantly more accurate imputation of missing values.
C. Joint classification and imputation performance
Most related literature in CADx naturally puts a focus
on classification performance. Imputation is an often over-
looked factor, even though it plays an important role in
population-based and multi-modal studies in medicine, as data
missingness is a common problem here [4]. When looking
at imputation performance in Fig. 2, we can see that the
proposed approach is able to significantly outperform standard
imputations such as mean, kNN, and MICE at all levels of
missingness, on both datasets. This suggests that the proposed
approach is able to take advantage of using known (semi-
supervised) class label information in order to impute the
features while simultaneously predicting the unknown class
labels. It further suggests that the proposed method learns
more class relevant feature representations compared to stan-
dard imputation approaches (mean, kNN, and MICE). We can
also observe that population modeling and graph incorporation
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Fig. 2: PPMI (left) and TADPPOLE (right) results: ROC-AUC (top), Accuracy (middle) and RMSE (bottom). Asterisk symbols
(*) denote that the tested model is statistically significantly different (two-tailed Wilcoxon rank-sum test, p ≤ 0.05) to our
proposed model (MGMC). X-axis values denote the percentage of available/known features prior to imputation and model
training.
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Fig. 3: PPMI (left) and TADPOLE (right) ablation results. ROC-AUC (top) and accuracy (bottom) results on test dataset. (*)
denote model is statistically significantly different (p ≤ 0.05) to proposed model. Values in x-axis denote relative percentage
of features which are available to the network.
cannot properly compensate for sub-optimal imputation, as
Mean+GCN results in PPMI are all inferior to the matrix
completion methods. Unfortunately, we cannot compare the
imputation results with other matrix completion works in
literature [11], [12], [13], [21], as those works do not report
imputation fidelity, e.g. via RMSE. However, we can compare
classification performance on TADPOLE data with [13], who
used the same subjects (examinations at baseline) and classes
(NC, MCI and AD) in TADPOLE as we did in our study. Here,
authors explored classification performance of their proposed
method, given 10% and 20% data missingness on either the
MRI or SNP modality. As authors in [13] report, the results
of our proposed approach are in line with their classification
accuracy results at 20% data missingness ( 60% accuracy)
which corroborates our results on 75% data availability in Fig.
2 right. Finally, it is noteworthy that our proposed approach
achieved a much better and stable classification performance
for the PPMI prediction task than for the TADPOLE prediction
task. A possible explanation is that distinguishing healthy
controls from PD may be a much simpler classification task
than the three-class classification problem in TADPOLE (NC
vs. MCI vs. AD). This notion is supported by clinical studies
arguing that distinguishing NC, MCI, and AD based on clinical
characteristics is a difficult problem at baseline [41].
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D. Ablation experiments
In section III-C, we described our proposed improvements
for usage of multiple RGCNs, specifically the usage of non-
autoregressive LSTMs over autoregressive ones. Autoregres-
sive RGCNs always use the output from the previous timestep
and information from the previous LSTM cell-block as input.
In contrast, non-autoregressive RGCNs always use the original
input features as input at every timestep. Our motivation for
using non-autoregressive LSTMs in MGMC is that the current
output is always conditioned on the original input features.
Intuitively, this should help the reconstructed output to avoid
diverging from the input data, which is a desirable behaviour in
matrix completion. Here, we perform and discuss an ablation
experiment, where we compare the effect of both, as shown
for PPMI and TADPOLE in Fig. 3. We observe that by using
non-autoregressive LSTMs, we obtain a significantly better
classification performance for all levels of data availability
in PPMI. In TADPOLE, this tendency is not as clear, and
a significant improvement is only achieved at 25% relative
available data. At 50%, 75% and 100% available data, non-
autoregressive LSTMs do not improve classification, but nei-
ther do they worsen the performance. This result suggests that
it is indeed preferable to use non-autoregressive LSTMs in
each parallel graph branch in MGMC. We attribute this to the
intuitive notion explained above: by conditioning the recon-
structed output on the original input data at every optimization
timestep, we stabilize the reconstruction and achieve a better
classification performance.
E. Overall implications
The main differences of our proposed approach to recent
works that use RGCNs for matrix completion [23], [21], [22]
are three-fold, namely i) the use of multiple LSTMs which are
non-autoregressive, ii) the use of self-attention weighting to
aggregate information from iii) multiple graphs representing
different neighborhood relationships between patients in the
population. Previous RGCN/GMC methods [23], [21] use a
single LSTM, while in our approach, we utilize one separate
LSTM for every graph, which results to multiple recurrent
graph convolutional networks (MRGCN). Notably, Monti et
al. [22] also use a multi-graph formulation, but their approach
differs from our method, since they consider both the rows and
columns of the feature matrix as two separate graph structures.
Instead, in this work, we consider multiple meta-information
as separate graphs that contain rows of a feature matrix as the
node features, similarly to [19].
Finally, our work has certain limitations, which may suggest
interesting avenues for future contributions. Following [17],
[16], our graph construction heuristic assumes a simple static
graph. An alternative approach would be to use the meta-
information and the feature matrix information in parallel to
build or learn the graph adjacency. Both approaches could
potentially lead to better performances of the downstream tasks
(classification and imputation). Another limitation is that we
benchmarked our proposed MGMC method to several baseline
methods (LR and RF) which are all inductive learning ap-
proaches. In contrast, our approach is inherently transductive,
as we rely on spectral graph convolutions in the parallel graph-
convolutional layers. We believe that it should be possible to
incorporate imputation losses into the objective functions of
GraphSAGE [42] or GAT [43] to obtain an inductive form
of MGMC, and it is worth investigating whether the same
benefits can be observed as in our experiments. Furthermore,
future works could compare against other non-deep learning
based techniques that tackle missing data such as [44] and
[45].
VI. CONCLUSION
In conclusion, we propose a novel automatic disease clas-
sification method which can handle multimodal data with
missing information, a common setup in medical population
based studies and datasets. We accomplish this by using Multi-
graph Geometric Matrix Completion (MGMC). We train our
architecture through Multiple Recurrent Graph Convolutional
Networks, which are optimized in an end-to-end manner.
Experimental results suggest the effectiveness of our proposed
approach on two well-known and challenging population based
studies of neurodegenerative Parkinson’s and Alzheimer’s dis-
eases. Furthermore, ablation experiments highlight the im-
portance of using non-autoregressive LSTM including the
effect of self-attention weighting. These results could serve
as a baseline for future works on disease classification in
incomplete datasets. In addition, this could be useful in other
domains where incomplete, multimodal, and high-dimensional
data is an issue.
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